Retirement Systems of Alabama lifted its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 8.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,413 shares of the medical instruments supplier’s stock after purchasing an additional 1,681 shares during the quarter. Retirement Systems of Alabama owned 0.10% of ICU Medical worth $6,055,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cerebellum GP LLC acquired a new position in ICU Medical during the third quarter worth $186,000. Mackay Shields LLC acquired a new position in ICU Medical during the second quarter worth $205,000. CIBC Asset Management Inc acquired a new position in ICU Medical during the second quarter worth $209,000. LPL Financial LLC acquired a new position in ICU Medical during the first quarter worth $218,000. Finally, First Hawaiian Bank acquired a new position in ICU Medical during the third quarter worth $226,000. Institutional investors and hedge funds own 73.51% of the company’s stock.
Shares of ICUI stock opened at $263.39 on Monday. The firm has a market cap of $5.39 billion, a PE ratio of 47.72 and a beta of 0.65. ICU Medical, Incorporated has a 52 week low of $180.45 and a 52 week high of $321.70.
ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 EPS for the quarter, topping the consensus estimate of $1.82 by $0.84. The company had revenue of $360.46 million for the quarter, compared to analysts’ expectations of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.76 earnings per share. On average, research analysts expect that ICU Medical, Incorporated will post 7.6 EPS for the current fiscal year.
Several research analysts have issued reports on ICUI shares. Zacks Investment Research lowered ICU Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, July 11th. ValuEngine lowered ICU Medical from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 3rd. TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th. Finally, BidaskClub cut ICU Medical from a “strong-buy” rating to a “buy” rating in a report on Thursday, September 20th.
In other news, VP Thomas D. Mccall sold 11,133 shares of the stock in a transaction on Friday, August 24th. The stock was sold at an average price of $302.56, for a total transaction of $3,368,400.48. Following the sale, the vice president now owns 3,018 shares in the company, valued at $913,126.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Pfizer Inc sold 700,000 shares of the stock in a transaction on Monday, August 13th. The stock was sold at an average price of $284.35, for a total value of $199,045,000.00. The disclosure for this sale can be found here. Insiders have sold 711,920 shares of company stock worth $202,651,956 in the last 90 days. Company insiders own 12.50% of the company’s stock.
ICU Medical Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Read More: Leveraged Buyout (LBO)
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.